Literature DB >> 9527626

Beta-estradiol protects hippocampal CA1 neurons against transient forebrain ischemia in gerbil.

S Sudo1, T C Wen, J Desaki, S Matsuda, J Tanaka, T Arai, N Maeda, M Sakanaka.   

Abstract

Beta-estradiol has been considered to be a neurotrophic agent, but its in vivo effect on gerbils with transient forebrain ischemia has not yet been demonstrated. In the first set of the present experiments, we infused beta-estradiol at a dose of 0.05 or 0.25 microg/day for 7 days into the lateral ventricles of normothermic gerbils starting 2 h before 3-min forebrain ischemia. Beta-estradiol infusion at a dose of 0.25 microg/day prevented significantly the ischemia-induced reduction of response latency time as revealed by a step-down passive avoidance task. Subsequent light and electron microscopic examinations showed that pyramidal neurons in the hippocampal CA1 region as well as synapses within the strata moleculare, radiatum and oriens of the region were significantly more numerous in gerbils infused with beta-estradiol than in those receiving saline infusion. Beta-estradiol at a dose of 1.25 microg/day was ineffective and occasionally increased the mortality of experimental animals. Since the total brain content of exogenous beta-estradiol at 12 h after forebrain ischemia was estimated to be less than 145 ng, the second set of experiments focused on the neurotrophic action of beta-estradiol at concentrations around 100 ng/ml in vitro. Beta-estradiol at concentrations of 1-100 ng/ml facilitated the survival and process extension of cultured hippocampal neurons, but it did not exhibit any significant radical-scavenging effects at the concentration range. On the other hand, 100 microg/ml of beta-estradiol, even though failing to support hippocampal neurons in vitro, effectively scavenged free radicals in subsequent in vitro studies, as demonstrated elsewhere. These findings suggest that beta-estradiol at a dose of 0.25 microg/day prevents ischemia-induced learning disability and neuronal loss at early stages after transient forebrain ischemia, possibly via a receptor-mediated pathway without attenuating free radical neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9527626     DOI: 10.1016/s0168-0102(97)00106-5

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  35 in total

1.  Aromatase is increased in astrocytes in the presence of elevated pressure.

Authors:  J W Gatson; J W Simpkins; K D Yi; A H Idris; J P Minei; J G Wigginton
Journal:  Endocrinology       Date:  2010-11-03       Impact factor: 4.736

2.  Protein phosphatase 1, protein phosphatase 2A, and calcineurin play a role in estrogen-mediated neuroprotection.

Authors:  Kun Don Yi; James W Simpkins
Journal:  Endocrinology       Date:  2008-06-19       Impact factor: 4.736

3.  Protective effect against 17beta-estradiol on neuronal apoptosis in hippocampus tissue following transient ischemia/recirculation in mongolian gerbils via down-regulation of tissue transglutaminase activity.

Authors:  K Fujita; T Kato; K Shibayama; H Imada; M Yamauchi; N Yoshimoto; E Miyachi; Y Nagata
Journal:  Neurochem Res       Date:  2006-07-28       Impact factor: 3.996

Review 4.  A novel mechanism of non-feminizing estrogens in neuroprotection.

Authors:  Elizabeth B Engler-Chiurazzi; Douglas F Covey; James W Simpkins
Journal:  Exp Gerontol       Date:  2016-11-03       Impact factor: 4.032

5.  Estrone is neuroprotective in rats after traumatic brain injury.

Authors:  Joshua W Gatson; Ming-Mei Liu; Kareem Abdelfattah; Jane G Wigginton; Scott Smith; Steven Wolf; James W Simpkins; Joseph P Minei
Journal:  J Neurotrauma       Date:  2012-05-08       Impact factor: 5.269

Review 6.  Astrocyte-derived growth factors and estrogen neuroprotection: role of transforming growth factor-α in estrogen-induced upregulation of glutamate transporters in astrocytes.

Authors:  Pratap Karki; Keisha Smith; James Johnson; Eunsook Lee
Journal:  Mol Cell Endocrinol       Date:  2014-01-18       Impact factor: 4.102

Review 7.  Sex differences in cognitive impairment and Alzheimer's disease.

Authors:  Rena Li; Meharvan Singh
Journal:  Front Neuroendocrinol       Date:  2014-01-13       Impact factor: 8.606

Review 8.  Estrogens and progesterone as neuroprotectants: what animal models teach us.

Authors:  Meharvan Singh; Nathalie Sumien; Cheryl Kyser; James W Simpkins
Journal:  Front Biosci       Date:  2008-01-01

Review 9.  Mitochondrial mechanisms of estrogen neuroprotection.

Authors:  James W Simpkins; Kun Don Yi; Shao-Hua Yang; James A Dykens
Journal:  Biochim Biophys Acta       Date:  2009-11-26

Review 10.  Estrogen and selective estrogen receptor modulators: neuroprotection in the Women's Health Initiative era.

Authors:  Stephanie Murphy; Louise McCullough; Marguerite Littleton-Kearney; Patricia Hurn
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.